China-Japan Friendship Hospital — Biomedical Watch V2

Traitements4programmes

Essais3liés

Publications0liées

SourceDBlocale

Traitements

4

Molécule	Indication / population	Phase	Objectif	Pays	Résultat
Ferric derisomaltoseThis randomized, double-blind, placebo-controlled clinical trial evaluates intravenous ferric derisomaltose in older adults with HFpEF and iron deficiency.	Insuffisance cardiaque, Maladie coronarienne	Phase 4	À vérifier	China	À vérifier
Ferric derisomaltoseThis randomized, double-blind, placebo-controlled clinical trial evaluates intravenous ferric derisomaltose in older adults with HFpEF and iron deficiency.	Insuffisance cardiaque	Phase 4	À vérifier	United States	À vérifier
Ferric derisomaltoseThis randomized, double-blind, placebo-controlled clinical trial evaluates intravenous ferric derisomaltose in older adults with HFpEF and iron deficiency.	Maladie coronarienne	Phase 4	À vérifier	China	À vérifier
Ferric derisomaltoseThis randomized, double-blind, placebo-controlled clinical trial evaluates intravenous ferric derisomaltose in older adults with HFpEF and iron deficiency.	Insuffisance cardiaque	Phase 4	À vérifier	China	À vérifier

Essais cliniques

3

Molécule	Indication / population	Phase	NCT	Titre	Statut
Ferric derisomaltose	Insuffisance cardiaque	Phase 4	NCT05991128	COREVIVE-HFpEF — The Effects of Ferric Derisomaltose in Patients With Acute Heart Failure and Iron Deficiency on Exercise Capacity and Quality of Life	RECRUITING
Ferric derisomaltose	Maladie coronarienne	Phase 4	NCT05971732	The Effects of Ferric Derisomaltose in Patients With Acute Heart Failure and Iron Deficiency on Exercise Capacity and Quality of Life(COREVIVE-HFrEF)	RECRUITING
Ferric derisomaltose	Insuffisance cardiaque	Phase 4	NCT07686692	INFUSE-HFpEF — IV Iron Therapy for Older Adults With Heart Failure With Preserved Ejection Fraction and Iron Deficiency	NOT_YET_RECRUITING

Publications

0

Molécule	Indication / population	Titre	Journal	Date
Aucune publication.